Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steroid hormones in multiple sclerosis.

Martine El-Etr1, Sandra Vukusic, Laurence Gignoux

  • 1INSERM U 488, Le Kremlin-Bicêtre, France.

Journal of the Neurological Sciences
|May 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.

Brain : a journal of neurology·2026
Same author

Updated French OFSEP recommendations for multiple sclerosis MRI: alignment with the 2024 McDonald criteria.

Journal of neuroradiology = Journal de neuroradiologie·2026
Same author

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact.

Annals of clinical and translational neurology·2026
Same author

Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.

Neurology·2026
Same author

French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

Neurology·2026

Steroid hormones may influence multiple sclerosis (MS) by affecting disease severity and relapses, particularly during pregnancy and postpartum. Research suggests sex steroids could offer therapeutic benefits for MS management.

Area of Science:

  • Neuroimmunology
  • Endocrinology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease with complex etiology.
  • Gender and hormonal fluctuations, particularly involving steroid hormones, are implicated in MS susceptibility and progression.

Purpose of the Study:

  • To investigate the role of steroid hormones in the clinical evolution and potential therapeutic strategies for multiple sclerosis.
  • To explore the immunological and neurological effects of sex steroids in the context of MS.

Main Methods:

  • Analysis of clinical data, including the influence of gender and pregnancy on MS relapse rates (e.g., PRIMS study).
  • Review of experimental animal studies examining the effects of sex steroids on immune responses and myelin repair.

Main Results:

Related Experiment Videos

  • A significant decrease in MS relapse rates was observed during pregnancy, especially in the third trimester.
  • A rebound increase in relapses occurred in the postpartum period.
  • Experimental studies demonstrated that sex steroids possess immunomodulatory effects and may promote myelin repair.

Conclusions:

  • Clinical and experimental evidence supports a significant role for steroid hormones in multiple sclerosis.
  • Sex steroids are potential therapeutic agents for managing MS relapses, particularly in the postpartum phase for women with MS.